GreenLight Clinical

Executive Summary

GreenLight Clinical is a physician-led, full-service CRO headquartered in Sydney, Australia, specializing in ophthalmology, oncology, rare diseases, and gene & cell therapy. Founded in 2015, the company employs 50-200 staff and provides end-to-end clinical trial support including project management, monitoring, data management, biostatistics, medical writing, and regulatory affairs. Its agile, solutions-focused approach and adherence to ICH GCP and ISO-9001 standards enable efficient, high-quality trial execution for small and mid-size biotech sponsors. As a private company with no disclosed funding or valuation, GreenLight Clinical has built a reputation for flexibility and expertise in niche therapeutic areas, positioning itself for growth as demand for specialized CRO services increases. The company's focus on complex and rare diseases, combined with its ability to adapt to sponsor needs, suggests a solid competitive advantage in the Australian and potentially Asia-Pacific clinical trial market.

Upcoming Catalysts (preview)

• Q4 2026Securing major contracts with mid-size biopharma in gene & cell therapy70% success
• Q2 2027Expansion into Asia-Pacific clinical trial operations60% success
• Q3 2026Achievement of additional quality certifications or regulatory accreditations80% success